Light the yule log and mull some cider if you live in the Northeast United States because chances of a white Christmas improve if snow still is on the ground by tomorrow, Dec. 18.
This holiday season, go out on a limb -- give the gift of graft. Without leaving home next spring, gardeners can learn to graft multiple fruit varieties onto a single fruit tree, create unusual growth forms and apply these skills to propagate plants that do not root easily.
Jeffrey S. Lehman, dean of the University of Michigan Law School and national leader in higher education, was appointed Cornell University's 11th president by the Board of Trustees at a special meeting held on campus today (Saturday, Dec. 14).
Weill Cornell Medical College has received a major $7.6-million award from the National Heart, Lung, and Blood Institute to establish a consortium that will support three clinical trials on new ways to help patients with cardiopulmonary disease.
Paul J. Chirik, assistant professor of chemistry and chemical biology at Cornell University, is one of this year's recipients of a Faculty Early Career Development Program grant from the National Science Foundation.
There are smart houses, smart cars and smart computers. Now get ready for smart clothes. At Cornell University that means a jacket that automatically heats and lights up when it is cold and dark and also contains a pulse monitor to measure activity level for joggers and walkers. (December 12, 2002)
Two Cornell undergraduates are among a very select group of students, nationwide, chosen to receive 2003 Rhodes Scholarships for two or three years of study at Oxford University in England.
The Executive Committee of the Cornell University Board of Trustees will hold a brief open session when it meets Thursday, Dec. 12, at 4 p.m. in the Fall Creek Room of the Cornell Club of New York, 6 E. 44th St., New York City.
Santa Claus around the world is known in many guises: He is Father Christmas in Britain and Kris Kringle in Germany. In Hawaii, Santa arrives by outrigger canoe, and in Australia, by water skis wearing a red bathing suit.
New York, NY (December 9, 2002) -- Gleevec, the new anti-leukemia drug from Novartis Pharmaceuticals, achieves a marked improvement in survival even for patients in the accelerated phase of chronic myeloid leukemia (CML), according to a study to be presented on Monday afternoon, Dec. 9, at the meeting of the American Society of Hematology (ASH) in Philadelphia.Comments Dr. Richard T. Silver, a professor at Weill Cornell Medical College and Attending Physician at NewYork-Presbyterian Hospital Weill Cornell Medical Center, who will present the findings: "Until now, the story of this disease has been like the story of Sisyphus who was condemned by the gods to roll a great stone up a mountain for all eternity. Gleevec has brought us a lot closer to the mountaintop than we've ever been."
Barbara T. Abrams, associate director of financial aid at Cornell University, has been elected to a three-year term on the board of directors of the National Indian Education Association (NIEA).
